Tingting Ma, Bei Cao, Lei Huang, Yuanxun Yang, Yan Geng, Pinhao Xie, . . . Juan Li. (2022). First-in-human study to assess the safety, tolerability, pharmacokinetics and immunogenicity of DS002, an anti-nerve growth factor monoclonal antibody. Frontiers Media S.A..
Chicago Style (17th ed.) CitationTingting Ma, et al. First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of DS002, an Anti-nerve Growth Factor Monoclonal Antibody. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationTingting Ma, et al. First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of DS002, an Anti-nerve Growth Factor Monoclonal Antibody. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.